President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart ...

The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.

A recent review and meta-analysis of semaglutide studies found that this drug can significantly reduce the risk of ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

In this edition of The People's Pharmacy, Joe and Teresa Graedon also hear from a reader who's worried about using petroleum jelly.

Weight loss that resulted from the drug was probably ... nine people who took GLP-1 antidiabetic drugs, including semaglutide. The review featured four semaglutide patients who developed ...

In the face of abrupt weight loss, one of the most common consequences is hair loss, even after bariatric surgery. Losing ...